13 April 2017
Valneva Reports Best Financial Results in the Company’s History with its First Year of Positive EBITDA in 2016
The Company expects to continue showing a strong financial performance in 2017.
- Total revenues and grants of €97.9 million in 2016 (vs €83.3 million in 2015) driven mainly by a 73.1% increase in IXIARO®/JESPECT® revenues;
- Valneva reported a positive EBITDA of €2.8 million in 2016 (vs. an EBITDA loss of €8.5 million in 2015);